WGS 117.21 ▲ 3.76% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    GeneDx Corp.

    NASDAQ: WGS · Real-Time Price · USD
    117.21
    4.25 (3.76%)
    At close: Sep 26, 2025, 3:59 PM
    114.72
    -2.12%
    After-hours: Sep 26, 2025, 06:23 PM EDT
    3.76%
    Bid 116.69
    Market Cap 3.37B
    Revenue (ttm) 362.32M
    Net Income (ttm) 1.41M
    EPS (ttm) 0.08
    PE Ratio (ttm) 1465.13
    Forward PE 46.06
    Analyst Buy
    Dividends n/a
    Ask 117.58
    Volume 416,659
    Avg. Volume (20D) 751,106
    Open 113.20
    Previous Close 112.96
    Day's Range 110.87 - 118.04
    52-Week Range 40.14 - 136.00
    Beta 2.10
    Ex-Dividend Date n/a

    About WGS

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol WGS
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for WGS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    GeneDx Corp. is scheduled to release its earnings on Oct 28, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription
    1 month ago
    +12.78%
    GeneDx Holdings shares are trading higher after We... Unlock content with Pro Subscription
    2 months ago
    +8.09%
    GeneDx shares are trading higher after the company raised FY25 sales guidance above estimates.
    news image

    1 day ago · businesswire.com

    GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference

    GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will introduce pediatricians to GeneDx's Infinity...

    news image

    1 week ago · zacks.com

    3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2025

    GeneDx, Twist Bioscience and Wave Life Sciences are emerging as key players in the fast-growing genomics and synthetic biology space.

    news image

    1 week ago · businesswire.com

    GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors

    GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors.

    news image

    1 month ago · zacks.com

    Will GENEDX HOLDINGS (WGS) Gain on Rising Earnings Estimates?

    GeneDx Holdings Corp. (WGS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

    news image

    1 month ago · zacks.com

    Should You Buy GeneDx Holdings Corp. (WGS) After Golden Cross?

    GeneDx Holdings Corp. (WGS) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, WGS's 50-day simple moving average broke out above its 2...

    news image

    1 month ago · businesswire.com

    GeneDx to Participate in Upcoming Investor Conferences

    GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS) today announced that company management will participate in upcoming investor conferences.

    news image

    1 month ago · seekingalpha.com

    GeneDx Surges Past Q2 Expectations, Sets Up For Strong Year-End Growth

    GeneDx delivered a strong Q2 2025, with revenues and earnings beating expectations and full-year guidance raised over 10%. Revenue growth is driven by higher testing volumes, improved reimbursement ra...

    news image

    1 month ago · fool.com

    Why GeneDx Holdings Stock Crushed It Again Today

    GeneDx (WGS 12.78%) shareholders are having quite a spectacular week, and it's not over yet. On Wednesday, the company's stock soared again, notching a nearly 13% pop after the previous day's 8%-plus ...

    1 month ago · youtube.com

    GeneDx CEO on rare disease diagnosis: Earlier testing gives families and clinicians more options

    Katherine Stueland, GeneDx CEO, joins 'Squawk Box' to discuss diagnosing children with rare diseases, cost structure of the tests, the fight against rare diseases, company growth outlook, deployment o...

    news image

    1 month ago · fool.com

    Why GeneDx Holdings Stock Blasted 8% Higher Today

    The stock of genetic testing company GeneDx Holdings (WGS 8.09%) was quite the hot item on the second trading day of the week. After the company published an encouraging second-quarter earnings report...

    Add to Watchlist